This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Adamczyk M, et al. risankizumab as an effective therapeutic option in severe psoriasis unsuccessfully treated with therapies involving anti-tnF-alpha and anti-iL-17. Przeglad Dermatologiczny 107: 385-392, No. 4, 2020. Available from: URL: http://doi.org/10.5114/dr.2020.99882